{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:50:16Z","timestamp":1782237016274,"version":"3.54.5"},"reference-count":27,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"DOI":"10.13039\/100017540","name":"NHLBI Division of Intramural Research","doi-asserted-by":"publisher","award":["ZIAHL006279"],"award-info":[{"award-number":["ZIAHL006279"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG058738"],"award-info":[{"award-number":["AG058738"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Heart failure (HF) is a complex syndrome with high mortality. Proteomics risk scores have shown promise in predicting mortality beyond guideline-recommended clinical tools. It is crucial to understand how risk scores generated by different methods and populations perform, and whether they highlight the same protein targets relevant to outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To examine whether the study design impacts proteomics scores designed to predict mortality in HF, we evaluated three published risk scores that used the SomaScan assay to measure plasma proteins in a community cohort, clinical trial, and registry. Each score was assessed in the aforementioned community cohort and Cox models examined the association of a 1-standard deviation increase in score with mortality, with and without adjustment for clinical covariates. Performance of each risk score to predict 5-year mortality risk was assessed using calibration plots and time-dependent area under the curve and compared with a clinical model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Risk scores were similarly distributed and moderately correlated (Pearson correlation coefficient\u2009=\u20090.59\u20130.76). A 1-standard deviation increase in each risk score was associated with an increased risk of all-cause mortality: community cohort (HR\u2009=\u20092.70, 95% CI: 2.50\u20132.91); clinical trial (HR\u2009=\u20091.76, 95% CI: 1.65\u20131.88); registry (HR\u2009=\u20091.70, 95% CI: 1.6\u20131.81). Risk remained after adjustment for clinical covariates, although slightly attenuated, and similar across different ejection fraction categories. All risk scores showed strong calibration across the risk levels, alone, with an average expected over observed ratio ranging between 0.96\u20131.56. Seven proteins were included in at least two risk scores, with renin being included in all three.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>All three proteomics risk scores improved risk stratification in HF patients beyond guideline recommended clinical tools, independent of study design and ejection fraction. These results demonstrate that proteomics risk scores can enhance risk stratification across the HF syndrome, even when derived from different methods and populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0350697","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:22:53Z","timestamp":1782235373000},"page":"e0350697","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Proteomics risk scores and mortality in heart failure: Generalizability across populations"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1443-7428","authenticated-orcid":true,"given":"Joseph J.","family":"Shearer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jungnam","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina G.","family":"Downie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3366-0702","authenticated-orcid":true,"given":"Kayode O.","family":"Kuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9702-9752","authenticated-orcid":true,"given":"Maryam","family":"Hashemian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette J.","family":"Bielinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9347-7865","authenticated-orcid":true,"given":"V\u00e9ronique L.","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"issue":"10","key":"pone.0350697.ref001","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.cardfail.2023.07.006","article-title":"Heart Failure Epidemiology and Outcomes Statistics: A Report of the Heart Failure Society of America","volume":"29","author":"B Bozkurt","year":"2023","journal-title":"J Card Fail"},{"issue":"10","key":"pone.0350697.ref002","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1038\/s41591-023-02567-2","article-title":"Recent successes in heart failure treatment","volume":"29","author":"CSP Lam","year":"2023","journal-title":"Nat Med"},{"issue":"6","key":"pone.0350697.ref003","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jamacardio.2024.0615","article-title":"Reversals in the Decline of Heart Failure Mortality in the US, 1999 to 2021","volume":"9","author":"A Sayed","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"4","key":"pone.0350697.ref004","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1456","article-title":"Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular Dysfunction","volume":"1","author":"PA Pellikka","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"17","key":"pone.0350697.ref005","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.jacc.2014.07.978","article-title":"The heterogeneity of heart failure: will enhanced phenotyping be necessary for future clinical trial success?","volume":"64","author":"GS Francis","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"pone.0350697.ref006","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"PA Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"pone.0350697.ref007","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12916-024-03249-7","article-title":"Proteomics for heart failure risk stratification: a systematic review","volume":"22","author":"KO Kuku","year":"2024","journal-title":"BMC Med"},{"issue":"1","key":"pone.0350697.ref008","doi-asserted-by":"crossref","first-page":"39","DOI":"10.7326\/M23-2328","article-title":"Development and Validation of a Protein Risk Score for Mortality in Heart Failure\u00a0: A Community Cohort Study","volume":"177","author":"KO Kuku","year":"2024","journal-title":"Ann Intern Med"},{"issue":"18","key":"pone.0350697.ref009","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1161\/CIRCULATIONAHA.122.061481","article-title":"Aptamer Proteomics for Biomarker Discovery in Heart Failure With Reduced Ejection Fraction","volume":"146","author":"L Zhang","year":"2022","journal-title":"Circulation"},{"issue":"3","key":"pone.0350697.ref010","article-title":"Plasma Proteomic Profile Predicts Survival in Heart Failure With Reduced Ejection Fraction","volume":"14","author":"H Gui","year":"2021","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"pone.0350697.ref011","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/ije\/dyx268","article-title":"Data Resource Profile: Expansion of the Rochester Epidemiology Project medical records-linkage system (E-REP)","volume":"47","author":"WA Rocca","year":"2018","journal-title":"Int J Epidemiol"},{"issue":"12","key":"pone.0350697.ref012","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.mayocp.2012.08.012","article-title":"History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population","volume":"87","author":"WA Rocca","year":"2012","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"pone.0350697.ref013","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jbi.2004.11.016","article-title":"Prospective recruitment of patients with congestive heart failure using an ad-hoc binary classifier","volume":"38","author":"SV Pakhomov","year":"2005","journal-title":"J Biomed Inform"},{"issue":"26","key":"pone.0350697.ref014","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJM197112232852601","article-title":"The natural history of congestive heart failure: the Framingham study","volume":"285","author":"PA McKee","year":"1971","journal-title":"N Engl J Med"},{"issue":"12","key":"pone.0350697.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015004","article-title":"Aptamer-based multiplexed proteomic technology for biomarker discovery","volume":"5","author":"L Gold","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"pone.0350697.ref016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0026332","article-title":"From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assay","volume":"6","author":"S Kraemer","year":"2011","journal-title":"PLoS One"},{"key":"pone.0350697.ref017","article-title":"SOMAmers and SOMAscan \u2013 a protein biomarker discovery platform for rapid analysis of sample collections from bench top to the clinic","volume":"24","author":"P Hensley","year":"2013","journal-title":"J Biomol Tech"},{"issue":"1","key":"pone.0350697.ref018","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"KGM Moons","year":"2015","journal-title":"Ann Intern Med"},{"issue":"9","key":"pone.0350697.ref019","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008242","article-title":"Participation in a Heart Failure Clinical Trial: Perspectives and Opportunities From the VICTORIA Trial and VICTORIA Simultaneous Registry","volume":"14","author":"J Ezekowitz","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"1","key":"pone.0350697.ref020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.cardfail.2024.07.001","article-title":"HF STATS 2024: Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America","volume":"31","author":"B Bozkurt","year":"2025","journal-title":"J Card Fail"},{"issue":"20","key":"pone.0350697.ref021","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1001\/jama.2012.14785","article-title":"Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction","volume":"308","author":"LH Lund","year":"2012","journal-title":"JAMA"},{"issue":"20","key":"pone.0350697.ref022","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association","volume":"148","author":"CE Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"5","key":"pone.0350697.ref023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0302203","article-title":"Demographic trends of cardiorenal and heart failure deaths in the United States, 2011-2020","volume":"19","author":"JJ Shearer","year":"2024","journal-title":"PLoS One"},{"issue":"8","key":"pone.0350697.ref024","first-page":"628","article-title":"2017 ACC\/AHA\/HFSA Focused Update of the 2013 ACCF\/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America","volume":"23","author":"CW Yancy","year":"2017","journal-title":"J Card Fail"},{"issue":"10","key":"pone.0350697.ref025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005958","article-title":"Contemporary Risk Stratification After Myocardial Infarction in the Community: Performance of Scores and Incremental Value of Soluble Suppression of Tumorigenicity-2","volume":"6","author":"Y Gerber","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"18","key":"pone.0350697.ref026","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/01.CIR.0000036598.12888.DE","article-title":"Scores for post-myocardial infarction risk stratification in the community","volume":"106","author":"M Singh","year":"2002","journal-title":"Circulation"},{"key":"pone.0350697.ref027","article-title":"SomaScan bioinformatics: normalization, quality control, and assessment of pre-analytical variation","author":"J Candia","year":"2024","journal-title":"bioRxiv"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350697","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T17:22:58Z","timestamp":1782235378000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0350697"}},"subtitle":[],"editor":[{"given":"Francesco","family":"Curcio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,23]]},"references-count":27,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0350697","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,23]]}}}